
Strateos, a DCVC/Lux Capital investment, is a pioneer in the development of remote access laboratories and lab automation software for life sciences discovery.
In 2021, Occam recruited David Lynch as the company’s CBO. Previously, David served as the VP of Business Development at Premier Research. Prior to his stint at Premier Research, David held various Business Development roles at biotechnology vendors & equipment manufacturers, such as PerkinElmer and Affymetrix.
Occam Global is a trusted executive search, consulting, and investment partner for leaders and investors shaping the future of life sciences, deep tech, and venture capital. Since 2012, we’ve helped build high-performing teams and advised visionary companies from stealth to public markets. Our success stems from exceptional access to rare talent, deep sector expertise, and a commitment to results guided by elevated ethics and enlightened aggression.